News Center

News Center

Sharing innovations in pharmaceutical formulations—stay ahead of the latest trends in chemical drugs at PharmaCon 2018.


Release date:

2018-11-05

1

November 1 Day -2 Day, the two-day PharmaCon2018 The 4th China International Forum on Chemical Drug R&D was held in Suzhou.

This summit brought together participants from home and abroad. 300 Leading researchers in chemical pharmaceuticals, along with executives from industry leaders and officials from drug regulatory agencies, came together to explore the common challenges and obstacles faced by domestic and international pharmaceutical companies—ranging from policy regulations and R&D technologies to emerging market trends. They shared insights into the latest developments and shifting dynamics, aiming to inspire fresh perspectives that could guide the industry’s future growth.

1

This conference aims to "deeply analyze the domestic and international environment for chemical drug development," with two days divided into four main venues: a dedicated session on chemical drug regulations, and another focused on drug discovery and synthesis in medicinal chemistry. CMC Special Session on Quality Research and Control, and Special Session on Novel Formulations and Delivery Systems.

1

Pan Huiping, Director of the Formulation Department at Shengshi Taikang Biopharmaceutical Technology (Suzhou) Co., Ltd., delivered a keynote speech as a heavyweight speaker in the special session on innovative formulations and drug delivery systems. She shared insights into the project initiation and development strategies for improved new drugs within fast-release formulations, effectively boosting enthusiasm among attendees at the conference’s dedicated session on cutting-edge formulations and delivery systems.

11

 

As the reform of the review and approval system continues to deepen, a series of initiatives—such as accelerating the evaluation and approval of innovative drugs, piloting the Marketing Authorization Holder (MAH) system, and optimizing the drug review and approval process—are being rapidly implemented. These measures have significantly boosted efficiency in the review and approval process, markedly improved the environment for chemical drug innovation, and enhanced the accessibility of innovative products.

PharmaCon provides Chinese chemical pharmaceutical companies with the premier conference platform, fostering industry-wide collaboration and advancement.